Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001493152-25-005657
Filing Date
2025-02-10
Accepted
2025-02-10 16:45:19
Documents
2
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 formdef14c.htm DEF 14C 95789
2 formdef14c_001.jpg GRAPHIC 10916
  Complete submission text file 0001493152-25-005657.txt   111994
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-42275 | Film No.: 25606310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)